RADMAB
Live / Registered — Registered (as of 26 Jan 2021)
What this means for you
Registered since 26 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79288877
- Registration number
- 6253802
- Mark type
- Stylized text
- Filed
- 02 Mar 2020
- Published for opposition
- 10 Nov 2020
- Registered
- 26 Jan 2021
- Attorney of record
- Andrew S. Ehard
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; all of the foregoing containing monoclonal antibodies
- Class 010 — Medical apparatus: Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices for diagnostic radiopharmaceuticals; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery devices sold empty being syringes, infusion sets and catheters
- Class 042 — Scientific and technological services: Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer
Owner
Prosecution history
- 26 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 Jan 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 14 Aug 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 May 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 30 Apr 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 30 Apr 2021 — FINAL DISPOSITION PROCESSED
- 26 Apr 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Nov 2020 — PUBLISHED FOR OPPOSITION
- 21 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Oct 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Sept 2020 — REFUSAL PROCESSED BY IB
- 22 Sept 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Sept 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE